Here are a few positive points, among the scores of depressing and horrifying anecdotes around Covid-19 that is leaving millions physically and psychologically sick. There are still many silver linings and all is not that gloomy.
Total Numbers: 381,529 cases so far; 16558 deaths showing less mortality compared to other pandemics
Recovery rate is still very good: 102,429 people recover, that is 86% of the closed cases
Mild cases: 250,484 (95%) of cases are still mild
Positive signs from Italy: For the second day, the death rate in Italy has declined, brightening the hopes. Another 601 people have died, down from 651 in the previous 24 hours and a record 793 the day before that. The number of new infections also rose at a slower rate: by 3,780 on Monday compared to 3,957 on Sunday.
China still in control: Once the epicenter of the global pandemic, China did not report no new domestic cases for almost a week now. All reported 34 new cases were imported from outside China.
The lock-down may not last for long: “I’m not looking at months, I can tell you that. Stop the Spread” 15-day effort would definitely end next week. We haven’t announced an end date but we are coming close to coming up with a date. We cannot let the cure be worse than the problem itself,” says US President Donald Trump
Good Global fight: Nearly 2 billion peopl stay at homes to contain the spread
Brave fight by India: Nine people died, and 468 tested positive in India. But still our fight is credible given the vast population. As many 22 states and Union Territories in lock-down.
Trials on antimalarial drug: The antimalarial drug hydroxychloroquine, along with Z-pack, will be ready for use in New York to treat COVID-19 patients on a clinical trial basis.
India allows hydroxy-chloroquine: The National Task Force for COVID-19, constituted by Indian Council of Medical Research (ICMR) has permitted the use of hydroxy-chloroquine for preventive treatment of healthcare workers and individuals in close contact of coronavirus patients.
Easier Testing: The US FDA is looking at a testing method that will allow people to collect their own sample. That will reduce risk to healthcare providers and speed the process.
More involvement from private sector likely: The Government has clarified that spending of CSR funds for COVID-19 is eligible CSR activity. “Funds may be spent for various activities related to COVID-19 relating to promotion of healthcare, including preventive health care and sanitation and disaster management,” ministry’s notification added.
WHO lauds India: The executive director of the World Health Organisation (WHO), Michael J Ryan, said that India has a tremendous capacity to deal the coronavirus outbreak situation as it has experience of eradicating two pandemics, namely small-pox and polio.